GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » Revenue per Share

Luyan Pharma Co (SZSE:002788) Revenue per Share : ¥52.13 (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co Revenue per Share?

Luyan Pharma Co's revenue per share for the three months ended in Mar. 2024 was ¥13.49. Luyan Pharma Co's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥52.13.

Warning Sign:

Luyan Pharma Co Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Luyan Pharma Co was 2.80% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 6.00% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 8.30% per year. During the past 10 years, the average Revenue Per Share Growth Rate was 10.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Luyan Pharma Co's Revenue per Share or its related term are showing as below:

SZSE:002788' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -0.3   Med: 10.3   Max: 28.4
Current: 6

During the past 13 years, Luyan Pharma Co's highest 3-Year average Revenue Per Share Growth Rate was 28.40% per year. The lowest was -0.30% per year. And the median was 10.30% per year.

SZSE:002788's 3-Year Revenue Growth Rate is ranked worse than
61.16% of 587 companies
in the Healthcare Providers & Services industry
Industry Median: 9.7 vs SZSE:002788: 6.00

Luyan Pharma Co Revenue per Share Historical Data

The historical data trend for Luyan Pharma Co's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co Revenue per Share Chart

Luyan Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.82 43.12 45.32 50.19 51.32

Luyan Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.73 13.25 11.83 13.56 13.49

Competitive Comparison of Luyan Pharma Co's Revenue per Share

For the Pharmaceutical Retailers subindustry, Luyan Pharma Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luyan Pharma Co's PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Luyan Pharma Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Luyan Pharma Co's PS Ratio falls into.



Luyan Pharma Co Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Luyan Pharma Co's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=19845.535/386.734
=51.32

Luyan Pharma Co's Revenue Per Share for the quarter that ended in Mar. 2024 is calculated as

Revenue Per Share (Q: Mar. 2024 )=Revenue (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=5135.681/380.802
=13.49

Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥52.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Luyan Pharma Co  (SZSE:002788) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Luyan Pharma Co Revenue per Share Related Terms

Thank you for viewing the detailed overview of Luyan Pharma Co's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Luyan Pharma Co (SZSE:002788) Business Description

Traded in Other Exchanges
N/A
Address
1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010
Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Executives
Zhu Ming Guo Executives
Yang Cong Jin Directors, executives
Lei Ming Directors, executives
Li Wei Yang Executives
Cai Mei Zhen Supervisors
Li Cui Ping Supervisors
Wu Jin Xiang Directors, executives
Zhang Jun Ying Executives
Wu Huo Lu Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines